J. Exp. Med., Volume 187, Number 9, May 4, 1998 1543-1548

BRIEF DEFINITIVE REPORT:
Vaccination with DNA Encoding an Immunodominant Myelin Basic Protein Peptide Targeted to Fc of Immunoglobulin G Suppresses Experimental Autoimmune Encephalomyelitis

By Anna Lobell,^* Robert Weissert, Maria K. Storch,^§ Cecilia Svanholm,^* Katrien L. de Graaf, Hans Lassmann,^§ Roland Andersson,^* Tomas Olsson, and Hans Wigzell^*

From the ^* Microbiology and Tumorbiology Center, Karolinska Institute, S-171 77 Stockholm, Sweden; the  Neuroimmunology Unit, Center for Molecular Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden; and the ^§ Neurological Institute, University of Vienna, A-1090 Vienna, Austria

We explore here if vaccination with DNA encoding an autoantigenic peptide can suppress autoimmune disease. For this purpose we used experimental autoimmune encephalomyelitis (EAE), which is an autoaggressive disease in the central nervous system and an animal model for multiple sclerosis. Lewis rats were vaccinated with DNA encoding an encephalitogenic T cell epitope, guinea pig myelin basic protein peptide 68-85 (MBP68-85), before induction of EAE with MBP68-85 in complete Freund's adjuvant. Compared to vaccination with a control DNA construct, the vaccination suppressed clinical and histopathological signs of EAE, and reduced the interferon  production after challenge with MBP68-85. Targeting of the gene product to Fc of IgG was essential for this effect. There were no signs of a Th2 cytokine bias. Our data suggest that DNA vaccines encoding autoantigenic peptides may be useful tools in controlling autoimmune disease.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Silver, P. B., Agarwal, R. K., Su, S.-B., Suffia, I., Grajewski, R. S., Luger, D., Chan, C.-C., Mahdi, R. M., Nickerson, J. M., Caspi, R. R. (2007). Hydrodynamic Vaccination with DNA Encoding an Immunologically Privileged Retinal Antigen Protects from Autoimmunity through Induction of Regulatory T Cells. J. Immunol. 179: 5146-5158 [Abstract] [Full Text]  
• Bar-Or, A., Vollmer, T., Antel, J., Arnold, D. L., Bodner, C. A., Campagnolo, D., Gianettoni, J., Jalili, F., Kachuck, N., Lapierre, Y., Niino, M., Oger, J., Price, M., Rhodes, S., Robinson, W. H., Shi, F.-D., Utz, P. J., Valone, F., Weiner, L., Steinman, L., Garren, H. (2007). Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial. Arch Neurol 64: 1407-1415 [Abstract] [Full Text]  
• Okura, Y., Miyakoshi, A., Kohyama, K., Park, I.-K., Staufenbiel, M., Matsumoto, Y. (2006). Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: Long-term effects and safety. Proc. Natl. Acad. Sci. USA 103: 9619-9624 [Abstract] [Full Text]  
• Ho, P. P., Fontoura, P., Platten, M., Sobel, R. A., DeVoss, J. J., Lee, L. Y., Kidd, B. A., Tomooka, B. H., Capers, J., Agrawal, A., Gupta, R., Zernik, J., Yee, M. K., Lee, B. J., Garren, H., Robinson, W. H., Steinman, L. (2005). A Suppressive Oligodeoxynucleotide Enhances the Efficacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune Disease. J. Immunol. 175: 6226-6234 [Abstract] [Full Text]  
• Hohlfeld, R., Wekerle, H. (2004). Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines. Proc. Natl. Acad. Sci. USA 101: 14599-14606 [Abstract] [Full Text]  
• Ho, P. P., Fontoura, P., Ruiz, P. J., Steinman, L., Garren, H. (2003). An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems. J. Immunol. 171: 4920-4926 [Abstract] [Full Text]  
• Seifarth, C., Pop, S., Liu, B., Wong, C. P., Tisch, R. (2003). More Stringent Conditions of Plasmid DNA Vaccination Are Required to Protect Grafted Versus Endogenous Islets in Nonobese Diabetic Mice. J. Immunol. 171: 469-476 [Abstract] [Full Text]  
• Lobell, A., Weissert, R., Eltayeb, S., de Graaf, K. L., Wefer, J., Storch, M. K., Lassmann, H., Wigzell, H., Olsson, T. (2003). Suppressive DNA Vaccination in Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis Involves a T1-Biased Immune Response. J. Immunol. 170: 1806-1813 [Abstract] [Full Text]  
• Bischof, F., Wienhold, W., Wirblich, C., Malcherek, G., Zevering, O., Kruisbeek, A. M., Melms, A. (2001). Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes. Proc. Natl. Acad. Sci. USA 10.1073/pnas.221220998v1 [Abstract] [Full Text]  
• Weaver, D. J. Jr., Liu, B., Tisch, R. (2001). Plasmid DNAs Encoding Insulin and Glutamic Acid Decarboxylase 65 Have Distinct Effects on the Progression of Autoimmune Diabetes in Nonobese Diabetic Mice. J. Immunol. 167: 586-592 [Abstract] [Full Text]  
• Tisch, R., Wang, B., Weaver, D. J., Liu, B., Bui, T., Arthos, J., Serreze, D. V. (2001). Antigen-Specific Mediated Suppression of {{beta}} Cell Autoimmunity by Plasmid DNA Vaccination. J. Immunol. 166: 2122-2132 [Abstract] [Full Text]  
• Lobell, A., Weissert, R., Eltayeb, S., Svanholm, C., Olsson, T., Wigzell, H. (1999). Presence of CpG DNA and the Local Cytokine Milieu Determine the Efficacy of Suppressive DNA Vaccination in Experimental Autoimmune Encephalomyelitis. J. Immunol. 163: 4754-4762 [Abstract] [Full Text]  
• Ruiz, P. J., Garren, H., Ruiz, I. U., Hirschberg, D. L., Nguyen, L.-V. T., Karpuj, M. V., Cooper, M. T., Mitchell, D. J., Fathman, C. G., Steinman, L. (1999). Suppressive Immunization with DNA Encoding a Self-Peptide Prevents Autoimmune Disease: Modulation of T Cell Costimulation. J. Immunol. 162: 3336-3341 [Abstract] [Full Text]  
• Weissert, R., Lobell, A., de Graaf, K. L., Eltayeb, S. Y., Andersson, R., Olsson, T., Wigzell, H. (2000). Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen. Proc. Natl. Acad. Sci. USA 97: 1689-1694 [Abstract] [Full Text]  
• Bischof, F., Wienhold, W., Wirblich, C., Malcherek, G., Zevering, O., Kruisbeek, A. M., Melms, A. (2001). Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes. Proc. Natl. Acad. Sci. USA 98: 12168-12173 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS